Get the Stockscreener App
23.38
3.35%
-0.81
Staar Surgical Co stock is traded at $23.38, with a volume of 488.84K.
It is down -3.35% in the last 24 hours and down -19.16% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
See More
Previous Close:
$24.19
Open:
$24.25
24h Volume:
488.84K
Relative Volume:
0.58
Market Cap:
$1.16B
Revenue:
$290.38M
Net Income/Loss:
$-21.03M
P/E Ratio:
-54.45
EPS:
-0.4294
Net Cash Flow:
$-54.99M
1W Performance:
-11.57%
1M Performance:
-19.16%
6M Performance:
+22.15%
1Y Performance:
+23.18%
1-Day Range:
$23.35
$24.34
1-Week Range:
$23.10
$26.35
52-Week Range:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
23.38 | 1.16B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-03-26 | Initiated | Wedbush | Neutral |
| Jan-16-26 | Resumed | Morgan Stanley | Underweight |
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
STAAR Surgical (STAA) Is Down 16.5% After Doubling Q2 2026 Sales Guidance – Has The Bull Case Changed? - Yahoo Finance
STAA Reiterated by Wedbush -- Price Target Maintained at $40 - GuruFocus
A Look at Staar Surgical Co (STAA) After 9.3% Decline -- GF Value $32.05 vs Price $23.97 - GuruFocus
STAAR Surgical Shows Strong Preliminary Q2 Results, With Double-Digit Sales Growth in Americas - VisionMonday.com
STAAR Surgical (STAA) Stock Could Be 12% Undervalued On Q2 Sales Recovery - simplywall.st
STAAR Surgical (STAA) Reports Strong Q2 Sales but Shares Drop - GuruFocus
STAAR Surgical (STAA) Shares Drop Despite Strong Q2 Revenue - GuruFocus
A Look at Staar Surgical Co (STAA) After 8.8% Decline -- GF Value $32.05 vs Price $26.44 - GuruFocus
Medical Device Stocks Decline Amid Insurance Changes - Intellectia AI
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know - Yahoo! Finance Canada
STAAR Surgical (STAA) Faces Significant Drop Despite Strong Q2 S - GuruFocus
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
Why is STAAR Surgical stock sliding today? By Investing.com - Investing.com South Africa
Caution Lingers for STAAR Surgical Amid Middle East Geopolitical Tensions - Benzinga
Staar Surgical China Turnaround Continues to Boost Confidence, Wedbush Says - 富途牛牛
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session - Benzinga
Why is STAAR Surgical stock sliding today? - Investing.com UK
STAAR Surgical Q2 net sales more than double on growth in China, Asia-Pacific, Americas - Bitget
Staar Surgical Dips 8.4% After Hours on Early Q2 Results - Orange County Business Journal
Canaccord reiterates STAAR Surgical stock rating on Q2 revenue beat - Investing.com
Canaccord reiterates STAAR Surgical stock rating on Q2 revenue beat By Investing.com - Investing.com Canada
STAAR Surgical Q2 sales exceed $90 million led by Asia growth - scanx.trade
Staar Surgical (STAA) Reports Strong Q2 Sales Amid Regional Chal - GuruFocus
STAAR Surgical reports Q2 sales to exceed $90 million - Investing.com
STAAR Surgical reports Q2 sales to exceed $90 million By Investing.com - Investing.com Canada
STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026 - Business Wire
Analysts Are Bullish on Top Healthcare Stocks: Staar Surgical (STAA), Definium Therapeutics (DFTX) - The Globe and Mail
STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth - AD HOC NEWS
3 Reasons to Avoid STAA and 1 Stock to Buy Instead - Yahoo Finance
STAAR SURGICAL CO (STAA) Stock Chart - ChartMill
STAAR Surgical clears a key FDA milestone, shares in the medical device sector spotlight - ad-hoc-news.de
STAAR Surgical (STAA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Form 4 STAAR Surgical Company For: 23 June By Investing.com - Investing.com Australia
5 must-read analyst questions from STAAR Surgical’s Q1 earnings call - MSN
Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options - Stock Titan
Form 4 STAAR Surgical Company For: 22 June By Investing.com - Investing.com Nigeria
STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike - Stock Titan
Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options - Stock Titan
STAAR Surgical (NASDAQ: STAA) director adds shares and options in equity grants - Stock Titan
STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO - Stock Titan
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
STAAR Surgical (STAA) director Jiang Wei exercises RSUs and receives new grant - Stock Titan
STAAR Surgical (STAA) director awarded RSUs and exercises prior units - Stock Titan
STAAR Surgical StockAnalyst views and long-term growth drivers - Ad-hoc-news.de
STAAR Surgical Co (STAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STAAR Surgical Co (STAA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
STAAR Surgical Co (STAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SILVERMAN LOU | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
11,158 |
| Jiang Wei | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
77,127 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 14 '26 |
Option Exercise |
0.00 |
29,325 |
0 |
63,588 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
3.37%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):